首页> 美国卫生研究院文献>Journal of Bacteriology >Proline carrier mutant of Escherichia coli K-12 with altered cation sensitivity of substrate-binding activity: cloning biochemical characterization and identification of the mutation.
【2h】

Proline carrier mutant of Escherichia coli K-12 with altered cation sensitivity of substrate-binding activity: cloning biochemical characterization and identification of the mutation.

机译:大肠杆菌K-12的脯氨酸载体突变体其对底物结合活性的阳离子敏感性发生了变化:克隆生化特性和突变鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two putP mutants of Escherichia coli K-12 that were defective in proline transport but retained the binding activities of the major proline carrier were isolated (T. Mogi, H. Yamamoto, T. Nakao, I. Yamato, and Y. Anraku, Mol. Gen. Genet. 202:35-41, 1986). One of these mutations and three null-type mutations (K. Motojima, I. Yamato, and Y. Anraku, J. Bacteriol. 136:5-9, 1978) were cloned into a pBR322 putP+ hybrid plasmid (pTMP5) by in vivo recombination. Cytoplasmic membrane vesicles were prepared from the mutant strains and strains harboring pTMP5 putP plasmids, and the properties of the proline-binding reaction of the mutant putP carriers in membranes were examined under nonenergized conditions. The putP19, putP21, and putP22 mutations, which were mapped in the same DNA segment of the putP gene (Mogi et al., Mol. Gen. Genet. 202:35-41, 1986), caused the complete loss of proline carrier activity. The proline carriers encoded by the mutant putP genes, putP9 and putP32, and putP32 in pTMP5-32, which was derived from in vivo recombination with the putP32 mutation, had altered sodium ion and proton dependence of binding affinities for proline and were resistant to N-ethylmaleimide inactivation without changes in the specificities for substrates and alkaline metal cations. The nucleotide sequence of the putP32 lesion located on the 0.35-megadalton RsaI-PvuII fragment in the putP gene in pTMP5-32 was determined; the mutation changed a cytosine at position 1001 to a thymine, causing the alteration of arginine to cysteine at amino acid position 257 in the primary structure of the proline carrier. It was shown that this one point mutation was enough to produce the phenotype of pTMP5-32 by in vitro DNA replacement of the AcyI-PvuII fragment of the wild-type putP gene with the DNA fragment containing the mutated nucleotide sequence.
机译:分离了两个脯氨酸运输有缺陷但保留了主要脯氨酸载体结合活性的大肠杆菌K-12的putP突变体(T. Mogi,H。Yamamoto,T。Nakao,I。Yamato和Y. Anraku,Mol Gen.Genet.202:35-41,1986)。通过体内将这些突变之一和三个无效型突变(K. Motojima,I。Yamato和Y. Anraku,J。Bacteriol。136:5-9,1978)克隆到pBR322 putP +杂交质粒(pTMP5)中重组。从突变菌株和带有pTMP5 putP质粒的菌株制备细胞质膜囊泡,并在无电条件下检查突变putP载体在膜中脯氨酸结合反应的性质。映射到putP基因同一DNA片段中的putP19,putP21和putP22突变(Mogi等人,Mol。Gen. Genet。202:35-41,1986)导致脯氨酸载体活性完全丧失。 。 pTMP5-32中突变的putP基因,putP9和putP32以及putP32编码的脯氨酸载体源自与putP32突变的体内重组,改变了钠离子和质子对脯氨酸结合亲和力的依赖性,并且对N有抗性-乙基马来酰亚胺失活,而对底物和碱金属阳离子的特异性不变。确定了位于pTMP5-32的putP基因中0.35兆尔顿RsaI-PvuII片段上的putP32病变的核苷酸序列;该突变将位置1001的胞嘧啶变为胸腺嘧啶,导致脯氨酸载体一级结构中第257位氨基酸的精氨酸变为半胱氨酸。已表明这一点突变足以通过用含有突变核苷酸序列的DNA片段对野生型putP基因的AcyI-PvuII片段进行体外DNA置换来产生pTMP5-32的表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号